PharmaShots | Incisive News in 3 Shots

Subscribe Now

Monrol

Monrol Partner Telix Report First Patient Dosing of TLX250 (177Lu-DOTA-girentuximab) in P-II (STARLITE 2) Study for Clear Cell Renal Cell Carcinoma

Monrol Partner Telix Report First Patient Dosing of TLX250 (177Lu-DOTA-girentuximab) in P-II (STARLITE 2) Study for Clear Cell Ren...

May 10, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us